Meri Petrosyan, MD

home / authors / meri-petrosyan-md

Articles

Opsoclonus-Myoclonus–Associated Neuroblastoma With Bone Marrow Metastases: What Would Be the Best Treatment Option?

Mane Gizhlaryan, MD;Tigran Aghabekyan;Tatev Arakelyan, MPH;Meri Petrosyan, MD;Samvel Iskanyan, MD;Gevorg Tamamyan, MD, Phd, MSc;Lilit Sargsyan, MD;Ruzanna Papyan, MD

October 22nd 2021

In this clinical quandary, investigators determine how to best treat patients with opsoclonus-myoclonus–associated neuroblastoma with bone marrow metastases.

Pediatric Locally Advanced Synovial Sarcoma: What Would Be the Best Treatment Option?

Meri Petrosyan, MD;Anna Avagyan, MD;Shushan Hovsepyan, MD;Zaven Koloyan, MD;Gevorg Tamamyan, MD, Phd, MSc;Ruzanna Papyan, MD;Arianna Mesrobian, BA

February 11th 2021

KEY POINTS • Synovial sarcomas are often mistreated with unplanned tumor resection. • Attention from specialists early in the course of SS can minimize the risk of recurrence, metastases, and the necessity for resurgery, all of which are increased with unplanned tumor resection. • Chemotherapy alone does not provide sufficient local control of the tumor. • Resurgery, in conjunction with radiotherapy and chemotherapy, is the best choice of management for this patient.